Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transport

Front Pharmacol. 2022 Sep 5:13:1014363. doi: 10.3389/fphar.2022.1014363. eCollection 2022.

Authors

Tim Quach¹, Luojuan Hu², Sifei Han², Shea F Lim¹, Danielle Senyschyn², Preeti Yadav², Natalie L Trevaskis², Jamie S Simpson¹, Christopher J H Porter²

Affiliations

¹ Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
² Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.879660.].

Keywords: buprenorphine; first-pass metabolism; lymphatic transport; opioid analgesics; oral bioavailability; prodrug; triglyceride mimetic.

Copyright © 2022 Quach, Hu, Han, Lim, Senyschyn, Yadav, Trevaskis, Simpson and Porter.

Publication types

Published Erratum